France· FR:69243168
ACETATE DE TERLIPRESSINE EVER PHARMA 0,2 mg/ml, solution injectable
A terlipressin product, registered in France by EVER VALINJECT (AUTRICHE). The same ATC class is registered in 15 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Terlipressin is registered in 15 of 19 countries.
Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Terlipressin · ATC H01BA04
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- EVER VALINJECT (AUTRICHE)
- Country
- France (FR)
- ATC code
- H01BA04
- ATC class
- Terlipressin
- Defined daily dose
- 12 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550312465 flacon(s) en verre de 5 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Terlipressin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGlypressin 1mg powder and solvent for solution for injection vialsFerring Pharmaceuticals Ltd
- SpainGLYPRESSIN 1 mg SOLUCION INYECTABLEFerring S.A.U.
- PolandGlypressinFerring GmbH
- SwitzerlandCurapressin 1 mg/5 ml, InjektionslösungCuratis AG
- IcelandGlypressinFerring Lægemidler A/S
- NetherlandsGlypressin 0,1 mg/ml, oplossing voor injectieFerring B.V.
- GermanyGlycylpressinFerring Gmbh
- United StatesTerlivazMallinckrodt Hospital Products Inc.
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Glycylpressin, Terlipressinacetat Ever Pharma
- Bulgaria · Терлипресин Ацетат Ever Pharma
- Czechia · Remestyp, Terlipresin Acetát Ever Pharma
- Germany · Glycylpressin, Terlipressinacetat Ever Pharma
- Spain · Terlipresina Acetato Ever Pharma
- Hungary · Glypressin
- Ireland · Terlipressin Acetate Ever Pharma
- Italy · Glipressina, Terlipressina Acetato Ever Pharma
- Poland · Terlipressini Acetas Ever Pharma
- Portugal · Glypressine, Terlipressina Ever Pharma
- Romania · Acetat De Terlipresină Ever Pharma
- Slovakia · Remestyp, Terlipresín Ever Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e97bf58-0bd0-43e2-9bdf-a3e1af00a985 GET /v1/drugs/8e97bf58-0bd0-43e2-9bdf-a3e1af00a985?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69243168",
"date_amm": "2017-04-03",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about terlipressin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.